Transamination is a biochemical reaction in which an amino group is transferred from an amino acid to a keto acid, producing a different amino acid and a different keto acid. It is a central process in metabolism, allowing organisms to redistribute amino nitrogen without directly releasing free ammonia. Most biological transamination reactions are catalyzed by aminotransferases, also called transaminases, which use pyridoxal phosphate as a cofactor. These reactions connect amino acid synthesis and breakdown with carbohydrate metabolism and cellular energy production.
General reaction and chemical significance
The typical reaction involving an α-amino acid can be written as:
An α-amino acid has its amino group attached to the carbon adjacent to the carboxyl group. In the corresponding α-keto acid, a carbonyl group occupies that position instead. Transamination exchanges these functional groups between two carbon skeletons.
A common amino-group acceptor is α-ketoglutarate, also known as 2-oxoglutarate. Acceptance of an amino group converts it into glutamate:
This arrangement makes glutamate a major collector and donor of amino groups. Different amino acids can transfer their nitrogen to the same acceptor, while the reverse reactions distribute glutamate nitrogen among different carbon skeletons.
Transamination differs from deamination, in which an amino group is removed with release of ammonia or ammonium. It also differs from amidation, which forms an amide group, as in the synthesis of glutamine from glutamate. Transamination alone does not produce a net gain or loss of amino nitrogen in the reacting metabolite pool.
Enzymes and cofactor mechanism
Pyridoxal phosphate
Most aminotransferases require pyridoxal phosphate (PLP), a metabolically active form of vitamin B6. PLP is a cofactor that temporarily carries the amino group and stabilizes reaction intermediates.
In the resting enzyme, PLP is commonly attached to a lysine residue through a Schiff base, a linkage containing a carbon–nitrogen double bond. This enzyme–cofactor linkage is called the internal aldimine. When an amino acid substrate binds, its amino group replaces the lysine amino group, forming a substrate–PLP external aldimine.
The conjugated structure of PLP stabilizes intermediates formed during rearrangement of bonds around the substrate’s α-carbon. This is why the same cofactor can support several kinds of amino acid chemistry; the enzyme’s active site determines which reaction is favored.
Two linked half-reactions
The transamination cycle consists of two half-reactions:
- Amino-group acquisition. The amino acid transfers its amino group to enzyme-bound PLP. The corresponding keto acid is released, and PLP becomes pyridoxamine phosphate (PMP).
- Amino-group donation. A second keto acid binds and receives the amino group from PMP. A new amino acid is released, regenerating PLP.
A simplified representation is:
where denotes the enzyme.
This is a ping-pong mechanism: one product is released before the second substrate reacts, and the enzyme cycles through two chemically distinct cofactor states. The complete reaction does not directly consume ATP and does not require a net input of reducing equivalents.
Representative reactions
Two extensively studied examples connect amino acid metabolism with central carbon metabolism.
Alanine aminotransferase
Alanine aminotransferase (ALT) catalyzes:
Pyruvate is also a product of glycolysis and a substrate for gluconeogenesis. This reaction therefore connects amino-group transfer with glucose metabolism.
In the glucose–alanine cycle, muscle can transfer amino nitrogen to pyruvate, forming alanine. Alanine travels to the liver, where the reverse transamination regenerates pyruvate and transfers the nitrogen to glutamate. The pyruvate can contribute to glucose synthesis, while the nitrogen enters pathways for nitrogen disposal.
Aspartate aminotransferase
Aspartate aminotransferase (AST) catalyzes:
Oxaloacetate is an intermediate of the citric acid cycle. Aspartate supplies one of the two nitrogen atoms incorporated into urea by the urea cycle.
Cytosolic and mitochondrial AST also participate in the malate–aspartate shuttle, which transfers reducing equivalents between the cytosol and the mitochondrial matrix. In this system, transamination supports transport and metabolite interconversion rather than serving solely in amino acid breakdown.
Roles in nitrogen metabolism
Amino acid degradation
During the breakdown of many amino acids, transamination transfers their amino groups to α-ketoglutarate. The resulting keto acids can enter pathways that oxidize their carbon skeletons or use them to form other metabolites.
Glutamate can subsequently undergo oxidative deamination, releasing ammonium and regenerating α-ketoglutarate. The combination of transamination with glutamate deamination is often called transdeamination. It provides a route by which nitrogen from several amino acids can be directed toward excretion without each amino acid requiring a separate ammonia-releasing reaction.
Transamination is not the initial degradative step for every amino acid. In human metabolism, lysine and threonine are commonly cited exceptions to the general pattern, while other amino acids also follow specialized pathways.
Amino acid synthesis
Because many transamination reactions are reversible, they can synthesize amino acids when suitable keto acids and amino-group donors are available. Glutamate, for example, can donate nitrogen to pyruvate to form alanine or to oxaloacetate to form aspartate.
This ability does not mean that animals can synthesize every amino acid. Production also requires an appropriate carbon skeleton and the necessary enzymes. Essential amino acids cannot be synthesized in sufficient amounts by the organism and must be obtained from the diet.
In plants and microorganisms, transamination distributes nitrogen that has already entered organic metabolism. It is not itself equivalent to nitrogen fixation, which converts molecular nitrogen into biologically available nitrogen compounds.
Reversibility, specificity, and cellular organization
Many transamination reactions operate near chemical equilibrium under cellular conditions. Their net direction depends on substrate and product concentrations and on the consumption of metabolites by other pathways. A reversible enzyme can therefore support amino acid synthesis in one setting and degradation in another.
Aminotransferases vary in substrate specificity. Some favor a relatively narrow set of amino acids, whereas others accept several related substrates. Branched-chain aminotransferases, for example, act on leucine, isoleucine, and valine. Specialized aminotransferases also act on compounds other than conventional α-amino acids, including intermediates in neurotransmitter and natural-product metabolism.
Location matters as well. Cytosolic and mitochondrial enzyme forms encounter different metabolite pools, and transport across membranes helps determine the overall flow of carbon and nitrogen.
Historical development and applications
Enzymatic transamination was established in 1937 through the work of Alexander Braunstein and Maria Kritzmann. The discovery demonstrated that amino groups could pass directly between organic molecules, providing an alternative to models in which amino acid nitrogen had to be released as ammonia before reuse. Subsequent work established the role of PLP and the two-half-reaction mechanism.
In clinical laboratory testing, ALT and AST activities are measured in blood as indicators of cellular injury. ALT is more closely associated with liver tissue, whereas AST is also abundant in several other tissues, including skeletal and cardiac muscle. Increased activity does not by itself identify a specific disease or directly measure liver function.
In biotechnology, aminotransferases are used to produce amino acids and chiral amines, including pharmaceutical intermediates. Their stereoselectivity can favor one configuration of a product. Industrial limitations include substrate acceptance, enzyme stability, product inhibition, and reaction equilibrium. Process design may address these constraints by using excess amino donor, removing a coproduct, or coupling transamination to another reaction.